Bromazolam formulations are a relatively novel development in the realm of treatments. These discrete increments offer a controlled method for supplying bromazolam, a potent CNS depressant. While studies on bromazolam pellets are still developing, early findings suggest their potential success in treating a variety of disorders. The distinct prop